<!DOCTYPE html>
<html>
<head>
<meta charset = "utf-8">
<title>204 淋巴性白血病</title>
<style type = "text/css">
table{width: 1100px; border-collapse: collapse; background-color: lightblue; font-family: sans-serif; margin:0px auto;}
table, td, th { border: 1px solid black; padding: 4px; }
th { text-align: left; color: white; background-color: darkblue; }
tr.oddrow { background-color: white; }
</style>
</head>
<body>
<table>
<caption>204-淋巴性白血病</caption>
<thead><tr><th>ICD 204</th>
<th>Gene/Locus name</th>
<th>Location</th>
<th>Gene/Locus</th>
<th>Gene/Locus MIM number</th>
<th>Phenotype MIM number</th>
<th>Match in DOID</th>
<th>Match in Orphanet</th>
<th>Match distinct gene</th>
</tr>
</thead>
<tbody>
<tr class='oddrow'><td>204</td><td>Lymphomatous acute lymphoblastic leukemia</td><td>9p22-p21</td><td>LALL</td><td><a href="https://www.omim.org/entry/247640?search=247640" target="_blank">247640</a></td><td><a href="https://www.omim.org/entry/247640?search=247640" target="_blank">247640</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>204</td><td>Leukemia, chronic lymphocytic, susceptibility to, 1</td><td>11p11</td><td>CLLS1</td><td><a href="https://www.omim.org/entry/609630?search=609630" target="_blank">609630</a></td><td><a href="https://www.omim.org/entry/609630?search=609630" target="_blank">609630</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>204</td><td>Leukemia, chronic lymphocytic, susceptibility to, 2</td><td>13q14</td><td>CLLS2, D13S25, DBM</td><td><a href="https://www.omim.org/entry/109543?search=109543" target="_blank">109543</a></td><td><a href="https://www.omim.org/entry/109543?search=109543" target="_blank">109543</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>204</td><td>BCL2-associated X protein</td><td>19q13.33</td><td>BAX</td><td><a href="https://www.omim.org/entry/600040?search=600040" target="_blank">600040</a></td><td><a href="https://www.omim.org/entry/613065?search=613065" target="_blank">613065</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>204</td><td>Breakpoint cluster region</td><td>22q11.23</td><td>BCR, CML, PHL, ALL</td><td><a href="https://www.omim.org/entry/151410?search=151410" target="_blank">151410</a></td><td><a href="https://www.omim.org/entry/613065?search=613065" target="_blank">613065</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>204</td><td>Guanine nucleotide-binding protein, beta polypeptide-1</td><td>1p36.33</td><td>GNB1, MRD42</td><td><a href="https://www.omim.org/entry/139380?search=139380" target="_blank">139380</a></td><td><a href="https://www.omim.org/entry/613065?search=613065" target="_blank">613065</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>204</td><td>fms-related tyrosine kinase-3</td><td>13q12.2</td><td>FLT3</td><td><a href="https://www.omim.org/entry/136351?search=136351" target="_blank">136351</a></td><td><a href="https://www.omim.org/entry/613065?search=613065" target="_blank">613065</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>204</td><td>T-cell acute lymphocytic leukemia-1</td><td>1p33</td><td>TAL1, TCL5, SCL</td><td><a href="https://www.omim.org/entry/187040?search=187040" target="_blank">187040</a></td><td><a href="https://www.omim.org/entry/613065?search=613065" target="_blank">613065</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>204</td><td>Nibrin</td><td>8q21.3</td><td>NBN, NBS1</td><td><a href="https://www.omim.org/entry/602667?search=602667" target="_blank">602667</a></td><td><a href="https://www.omim.org/entry/613065?search=613065" target="_blank">613065</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>204</td><td>Nucleoporin, 214kD</td><td>9q34.13</td><td>NUP214, D9S46E, CAN, CAIN</td><td><a href="https://www.omim.org/entry/114350?search=114350" target="_blank">114350</a></td><td><a href="https://www.omim.org/entry/613065?search=613065" target="_blank">613065</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>204</td><td>T-cell acute lymphocytic leukemia-2</td><td>9q31.2</td><td>TAL2</td><td><a href="https://www.omim.org/entry/186855?search=186855" target="_blank">186855</a></td><td><a href="https://www.omim.org/entry/613065?search=613065" target="_blank">613065</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>204</td><td>Leukemia, acute lymphoblastic, susceptibility to, 2</td><td>7p12.2</td><td>ALL2</td><td><a href="https://www.omim.org/entry/613067?search=613067" target="_blank">613067</a></td><td><a href="https://www.omim.org/entry/613067?search=613067" target="_blank">613067</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>204</td><td>Leukemia, chronic lymphocytic susceptibility to, 5</td><td>11q24.1</td><td>CLLS5</td><td><a href="https://www.omim.org/entry/612559?search=612559" target="_blank">612559</a></td><td><a href="https://www.omim.org/entry/612559?search=612559" target="_blank">612559</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>204</td><td>Leukemia, chronic lymphocytic, susceptibility to, 3</td><td>9q34.1</td><td>CLLS3</td><td><a href="https://www.omim.org/entry/612557?search=612557" target="_blank">612557</a></td><td><a href="https://www.omim.org/entry/612557?search=612557" target="_blank">612557</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>204</td><td>Leukemia, chronic lymphocytic susceptibility to, 4</td><td>6p25</td><td>CLLS4</td><td><a href="https://www.omim.org/entry/612558?search=612558" target="_blank">612558</a></td><td><a href="https://www.omim.org/entry/612558?search=612558" target="_blank">612558</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>204</td><td></td><td></td><td></td><td><a href="https://www.omim.org/entry/?search=" target="_blank"></a></td><td><a href="https://www.omim.org/entry/151400?search=151400" target="_blank">151400</a></td><td>YES</td><td></td><td></td></tr>
</tbody></table>
</body>
</html>
